May 31, 2016 — CorTechs Labs and Olea Medical announced a partnership agreement to offer NeuroQuant in Olea Sphere, Olea Medical’s suite of imaging applications.
The partnership will enrich physicians’ resources for accessing and quantifying neurodegeneration. NeuroQuant from CorTechs provides automatic, accurate and consistent measurements of brain structures through 3-D T1 magnetic resonance imaging (MRI). This allows neurologists and radiologists to easily review, assess, quantify and monitor brain volume loss and changes over time as compared to normative values.
NeuroQuant is U.S. Food and Drug Administration (FDA)-leared, CE marked and Health Canada licensed for measuring brain volumes and quantifying brain atrophy. It is used in the assessment of neurodegeneration, such as Alzheimer’s disease, epilepsy and multiple sclerosis as well as brain volume changes caused by brain trauma.
Olea Sphere is an image processing software package intended for picture archive, post-processing and communication. It helps standardize both viewing and analysis capabilities of functional and dynamic imaging datasets acquired with MRI and computed tomography (CT) across vendors. It features image viewing, analysis and processing of most complex MR sequences as well as longitudinal analysis of multiple time points. Olea Sphere is compliant with the DICOM standard and Windows or Linux operating systems. The software runs on any standard off-the-shelf workstation or it can be used through thin deployment.
For more information: www.cortechslabs.com, www.olea-medical.com
February 13, 2026 
